IQVIA Holdings Inc. (NYSE:IQV), a global leader in advanced analytics, technology solutions, and clinical research services for the healthcare and life sciences industries, finds itself at a critical ...

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category on the 2025 Fortune® World’s Most Admired ...

Durham, North Carolina-based IQVIA Holdings Inc. (IQV) provides healthcare research services. Valued at $35.8 billion by market cap, the company offers analytics, technology solutions, and clinical ...

BTIG analyst David Larsen downgraded Iqvia (IQV) to Neutral from Buy without a price target The firm says clinical research organization ...

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia ...

The injury data are compiled and analyzed by IQVIA, an independent, third-party company retained by the NFL.

Barclays lowered the firm’s price target on Iqvia (IQV) to $235 from $255 and keeps an Overweight rating on the shares. The firm says the life ...

Shares of IQVIA Holdings Inc. IQV slipped 1.12% to $199.11 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.76% to 5,994.57 ...

This collaboration between IQVIA and NVIDIA will help ... and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain ...

The healthcare and life sciences industries generate vast amounts of data, representing ... The collaboration will combine IQVIA’s unparalleled information assets, analytics, and domain ...